Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
Triple-negative breast cancers are heterogeneous, poorly prognostic, and metastatic malignancies that result in a high risk of death for patients. Targeted therapy for triple-negative breast cancer has been extremely challenging due to the lack of expression of estrogen receptor, progesterone recept...
Saved in:
Main Authors: | Wenjie Zhao (Author), Jinhua Liu (Author), Yaqun Li (Author), Zichao Chen (Author), Dongmei Qi (Author), Zhen Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy Summary for Cytokine Storm in COVID-19
by: Yaqun Li, et al.
Published: (2021) -
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
by: Jinhua Liu, et al.
Published: (2021) -
Chinese Herbal Medicines Facilitate the Control of Chemotherapy-Induced Side Effects in Colorectal Cancer: Progress and Perspective
by: Dongmei Chen, et al.
Published: (2018) -
Is there an epigenetic component underlying the resistance of triple-negative breast cancers to PARP inhibitors?
by: Amanda eLovato, et al.
Published: (2012) -
Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021)